In the fourth episode of the Arqus podcast, we tackle yet again basic research. This time our topic is the design and development of drug delivery nanosystems, namely nanomedicines, for cancer therapy. A promising approach in this field is to engineer nanomedicines to stimulate a specific immune response against cancers. Giovanna Lollo from the Laboratory of Automatic Control, Chemical and Pharmaceutical Engineering of the Université de Lyon explains this approach to us.

Note: The vaccines Giovanna refers to are the ones developed by Moderna and BioNTech/Pfizer. In the time that has passed between the recording and the publication of this podcast, those two have gained international recognition as they were among the first authorized vaccines against SARS-CoV-2